NIH researchers created an AI tool to predict cancer patient response to immunotherapy drugs using blood test data.

NIH researchers developed an AI tool to predict cancer patient response to immunotherapy drugs, using routine clinical data from blood tests. The machine-learning model, published in Nature Cancer, could help doctors determine the effectiveness of immunotherapy treatments. This AI tool complements the two FDA-approved predictive biomarkers for treating patients with immune checkpoint inhibitors.